-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chromomycin A3 is an important antibiotic that is widely used to treat a variety of bacterial infections.
It is a polyketide antibiotic, which means that it is produced by a type of bacteria called Streptomyces.
The bacteria produce the antibiotic as a metabolic byproduct, and it is extracted and purified for use as a medication.
There are several synthetic routes that can be used to produce Chromomycin A3, and the choice of route depends on a variety of factors, including the scale of production, the availability of starting materials, and the desired purity of the final product.
One of the most common synthetic routes for Chromomycin A3 involves the use of a chemical reaction called the Widmer-Rennstich reaction.
This reaction involves the condensation of a compound called phenyl acetate with a compound called salicylic acid, in the presence of a strong acid catalyst.
The reaction produces a intermediate compound called phenyl salicylate, which is then transformed into Chromomycin A3 through a series of subsequent chemical reactions.
Another synthetic route for Chromomycin A3 involves the use of a chemical reaction called the Pictet-Spengler reaction.
This reaction involves the condensation of a compound called a carboxylic acid with a compound called a phenol, in the presence of a strong acid catalyst.
The reaction produces a intermediate compound called a phenolic acid, which is then transformed into Chromomycin A3 through a series of subsequent chemical reactions.
Both of these synthetic routes require the use of starting materials that are relatively expensive and difficult to obtain, and they also require the use of harsh chemicals and high temperatures, which can make the process less environmentally friendly.
Recently, researchers have developed a new synthetic route for Chromomycin A3 that involves the use of enzymes instead of harsh chemicals.
This route is more environmentally friendly and also produces a purer product than the traditional synthetic routes.
In this route, the enzyme phenyl acetate decarboxylase is used to convert phenyl acetate into phenylacetone, which is then transformed
